Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Assure Holdings Corp.IONM · Entity 114497 | CFO | November 18, 2022 | November 22, 2022 |
| Coda Octopus Group, Inc.CODA · Entity 6690 | Chief Financial Officer. | November 27, 2023 | November 29, 2023 |
| NewAge, Inc.NBEV · Entity 129046 | Chief Financial Officer | August 15, 2018 | August 24, 2018 |
| PANACEA LIFE SCIENCES HOLDINGS, INC.EXDI · Entity 9699 | Director | November 20, 2019 | November 22, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Assure Holdings Corp.
Report date November 18, 2022 · Filed November 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 81,413 |
Reported balance
After 2022-11-18 transaction · row 1
1 source rowRow 1 · 2022-11-18 · Purchase · Acquired 67,713 · Balance 81,413 |
Coda Octopus Group, Inc.
Report date November 27, 2023 · Filed November 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2023-11-27 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F1: Does not include 8,130 shares to be issued in three equal annual installments commencing February 27, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Does not include 8,130 shares to be issued in three equal annual installments commencing February 27, 2024.
NewAge, Inc.
Report date August 15, 2018 · Filed August 24, 2018
This filing explicitly reported no securities owned.
PANACEA LIFE SCIENCES HOLDINGS, INC.
Report date November 20, 2019 · Filed November 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,000 |
Reported balance
After 2019-11-20 transaction · row 1
1 source rowRow 1 · 2019-11-20 · Grant · Acquired 100,000 · Balance 100,000 F1: Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director. |
| Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.20 · Expires 2029-02-11 | Direct | 250,000 |
Reported balance
Holding disclosure · report date 2019-11-20 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 250,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SCWorx Corp.
Report date December 11, 2019 · Filed December 14, 2019
Section 16 reporting ended · disclosed 2019-12-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,000 |
Reported balance
After 2019-12-11 transaction · row 1
1 source rowRow 1 · 2019-12-11 · Sale · Disposed 5,000 · Balance 20,000 F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.2000 to $3.2700 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.2000 to $3.2700 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2022 Filed Nov 22, 2022 18:58 UTC | Assure Holdings Corp. IONM · Entity 114497 | PurchaseCommon stock | 67,713 | $0.60 | $40,627.80 |
DisclosureSEC source: 0001415889-22-011705 · form4-11222022_111106.xml · nonDerivative · entry 1 Price John C · CIK 0001636242 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,413 Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 16:23 UTC | Assure Holdings Corp. IONM · Entity 114497 | PurchaseCommon stock | 13,700 | $6.19 | $84,803.00 |
DisclosureSEC source: 0001415889-21-005615 · form4-12012021_011254.xml · nonDerivative · entry 1 Price John C · CIK 0001636242 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 Read SEC document |
| December 11, 2019 Filed Dec 14, 2019 02:30 UTC | SCWorx Corp. WORX · Entity 8668 | SaleCommon Stock | 5,000 | $3.23 | $16,147.50 |
DisclosureSEC source: 0001104659-19-072699 · tm1924631d2_4.xml · nonDerivative · entry 1 Price John C · CIK 0001636242 · Former CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.2000 to $3.2700 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 23:04 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001390 · form4-11222019_031127.xml · nonDerivative · entry 1 Price John C · CIK 0001636242 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · shares: Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director. Read SEC document |
| February 13, 2019 Filed Feb 21, 2019 01:06 UTC | SCWorx Corp. WORX · Entity 8668 | GrantRestricted Stock Units (common stock) | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-009174 · tv513915_4.xml · nonDerivative · entry 4 Price John C · CIK 0001636242 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F4 · shares: These RSUs vest if and when the Issuer's stock price attains a VWAP of $40 per share for 15 consecutive trading days. F5 · price: The Issuer granted these RSUs to the reporting person in consideration for services to be rendered to the Issuer. Read SEC document |
| February 13, 2019 Filed Feb 21, 2019 01:06 UTC | SCWorx Corp. WORX · Entity 8668 | GrantRestricted Stock Units (common stock) | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-009174 · tv513915_4.xml · nonDerivative · entry 3 Price John C · CIK 0001636242 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F3 · shares: These RSUs vest if and when the Issuer's stock price attains a volume weighted average price ("VWAP") of $20 per share for 15 consecutive trading days. F5 · price: The Issuer granted these RSUs to the reporting person in consideration for services to be rendered to the Issuer. Read SEC document |
| February 13, 2019 Filed Feb 21, 2019 01:06 UTC | SCWorx Corp. WORX · Entity 8668 | GrantRestricted Stock Units (common stock) | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-009174 · tv513915_4.xml · nonDerivative · entry 2 Price John C · CIK 0001636242 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F2 · shares: These RSUs vest only if the Issuer obtains $10M in new recurring revenue on or before 08/15/20. F5 · price: The Issuer granted these RSUs to the reporting person in consideration for services to be rendered to the Issuer. Read SEC document |
| February 13, 2019 Filed Feb 21, 2019 01:06 UTC | SCWorx Corp. WORX · Entity 8668 | GrantRestricted Stock Units (common stock) | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-009174 · tv513915_4.xml · nonDerivative · entry 1 Price John C · CIK 0001636242 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 F1 · shares: These Restricted stock Units ("RSUs") vest in quarterly installments over three years, commencing August 15, 2019. F5 · price: The Issuer granted these RSUs to the reporting person in consideration for services to be rendered to the Issuer. Read SEC document |
| June 06, 2018 Filed Jun 22, 2018 20:02 UTC | SCWorx Corp. AMMA · Entity 8668 | GrantOption to Purchase Common Stock · Derivative | 200,000 | Not disclosed Strike: $0.36 | Not disclosed |
DisclosureSEC source: 0001144204-18-035362 · tv496052_4.xml · derivative · entry 2 Price John C · CIK 0001636242 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock, par value $0.001 · 200,000 shares Expires 2023-06-06 F1 · price: On June 6, 2018, the issuer cancelled the option granted to the reporting person on August 10, 2016 for 200,000 shares at $4.50 per share. In exchange, the reporting person received the option reported herein. Read SEC document |
| June 06, 2018 Filed Jun 22, 2018 20:02 UTC | SCWorx Corp. AMMA · Entity 8668 | Disposition to issuerOption to Purchase Common Stock · Derivative | 200,000 | Not disclosed Strike: $4.50 | Not disclosed |
DisclosureSEC source: 0001144204-18-035362 · tv496052_4.xml · derivative · entry 1 Price John C · CIK 0001636242 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 200,000 shares Expires 2026-08-10 F1 · price: On June 6, 2018, the issuer cancelled the option granted to the reporting person on August 10, 2016 for 200,000 shares at $4.50 per share. In exchange, the reporting person received the option reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.